Clinical Trial: A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Adults Aged 18 Years and Older (China)

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Adults Aged 18 Years and Older'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133932

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: Jiangsu Provincial Center for Disease Control and Prevention

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345563

Published by HT Digital Content Services with permission from Health Daily Digest....